Literature DB >> 20187776

Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity.

Divaker Choubey1, Xin Duan, Eric Dickerson, Larissa Ponomareva, Ravichandran Panchanathan, Hui Shen, Ratika Srivastava.   

Abstract

Deregulated innate immune responses that result in increased levels of type I interferons (IFNs) and stimulation of IFN-inducible genes are thought to contribute to chronic inflammation and autoimmunity. One family of IFN-inducible genes is the Ifi200 family, which includes the murine (eg, Ifi202a, Ifi202b, Ifi203, Ifi204, Mndal, and Aim2) and human (eg, IFI16, MNDA, IFIX, and AIM2) genes. Genes in the family encode structurally related proteins (the p200-family proteins), which share at least one partially conserved repeat of 200-amino acid (200-AA) residues. Consistent with the presence of 2 consecutive oligonucleotide/oligosaccharide-binding folds in the repeat, the p200-family proteins can bind to DNA. Additionally, these proteins (except the p202 proteins) also contain a pyrin (PYD) domain in the N-terminus. Increased expression of p202 proteins in certain strains of female mice is associated with lupus-like disease. Interestingly, only the Aim2 protein is conserved between the mouse and humans. Several recent studies have provided evidence that the Aim2 and p202 proteins can recognize DNA in cytoplasm and the Aim2 protein upon sensing DNA can form a caspase-1-activating inflammasome. In this review, we discuss how the ability of p200-family proteins to sense cytoplasmic DNA may contribute to the development of chronic inflammation and associated diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187776      PMCID: PMC2947464          DOI: 10.1089/jir.2009.0096

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  82 in total

Review 1.  P202: an interferon-inducible negative regulator of cell growth.

Authors:  D Choubey
Journal:  J Biol Regul Homeost Agents       Date:  2000 Jul-Sep       Impact factor: 1.711

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes.

Authors:  Suguru Hasegawa; Yoichi Furukawa; Meihua Li; Seiji Satoh; Tatsushi Kato; Takeshi Watanabe; Toyomasa Katagiri; Tatsuhiko Tsunoda; Yoshio Yamaoka; Yusuke Nakamura
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

4.  The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain.

Authors:  D Choubey; J U Gutterman
Journal:  Biochem Biophys Res Commun       Date:  1996-04-16       Impact factor: 3.575

Review 5.  Interferon-inducible p202 in the susceptibility to systemic lupus.

Authors:  Divaker Choubey; Brian L Kotzin
Journal:  Front Biosci       Date:  2002-05-01

6.  Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus.

Authors:  S J Rozzo; J D Allard; D Choubey; T J Vyse; S Izui; G Peltz; B L Kotzin
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

7.  Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons.

Authors:  L Aravind; V M Dixit; E V Koonin
Journal:  Science       Date:  2001-02-16       Impact factor: 47.728

8.  p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.

Authors:  B Datta; B Li; D Choubey; G Nallur; P Lengyel
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

9.  Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma.

Authors:  K L DeYoung; M E Ray; Y A Su; S L Anzick; R W Johnstone; J A Trapani; P S Meltzer; J M Trent
Journal:  Oncogene       Date:  1997-07-24       Impact factor: 9.867

10.  Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

Authors:  Marie-Laure Santiago-Raber; Roberto Baccala; Katarina M Haraldsson; Divaker Choubey; Timothy A Stewart; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  51 in total

Review 1.  Interferons in autoimmune and inflammatory diseases: regulation and roles.

Authors:  Divaker Choubey; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

2.  Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation.

Authors:  Maninjay K Atianand; Ellen B Duffy; Aaloki Shah; Supriya Kar; Meenakshi Malik; Jonathan A Harton
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

Review 3.  Intracellular sensing of microbes and danger signals by the inflammasomes.

Authors:  Gabor L Horvath; Jacob E Schrum; Christine M De Nardo; Eicke Latz
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 4.  Interferons as inducers of apoptosis in malignant cells.

Authors:  Kevin P Kotredes; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

5.  Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE.

Authors:  Ravichandran Panchanathan; Xin Duan; Muthuvel Arumugam; Hui Shen; Hongzhu Liu; Divaker Choubey
Journal:  Mol Immunol       Date:  2011-09-23       Impact factor: 4.407

Review 6.  Absent in Melanoma 2 proteins in SLE.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Clin Immunol       Date:  2017-01-03       Impact factor: 3.969

Review 7.  Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins.

Authors:  Sudhakar Veeranki; Divaker Choubey
Journal:  Immunol Lett       Date:  2010-06-26       Impact factor: 3.685

8.  DNA Vaccines for Prostate Cancer.

Authors:  Douglas G McNeel; Jordan T Becker; Laura E Johnson; Brian M Olson
Journal:  Curr Cancer Ther Rev       Date:  2012-11-01

Review 9.  Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.

Authors:  Divaker Choubey
Journal:  Immunol Lett       Date:  2012-07-24       Impact factor: 3.685

Review 10.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.